Lower incidence of vasospasm after aneurysmal subarachnoid haemorrhage in the elderly patient? A prospective clinical series

D. Wachter & V. Rohde
Objective: Vasospasm is the major cause of morbidity and mortality after aneurysmal subarachnoid haemorrhage (SAH). Anti-vasospastic therapy often is initiated prophylactically to avoid vasospasm-associated delayed ischemic neurological deficits (DIND). However, this therapy also carries risks and has[for full text, please go to the a.m. URL]